Den overordnede sikkerhedsprofil for Xeloda er baseret på data fra flere end 3000 patienter, der fik Xeloda- monoterapi eller Xeloda i kombination med forskellige kemoterapiregimer indenfor flere indikationer.
The overall safety profile of Xeloda is based on data from over 3000 patients treated with Xeloda as monotherapy or Xeloda in combination with different chemotherapy regimens in multiple indications.